Calm the farm indeed gents!
Interpret this: (August 10, 2012)
"Dr Horrigan's appointment, Larry Glass, Neuren's CEO, said: "We are delighted to have Joe join the company. His expertise and insight will contribute immensely to our clinical development programs. As we advance the clinical trials in neurodevelopmental disorders and head injury, Joe's leadership and perspective will be critical to study design and execution in these important and challenging indications which clearly depend on creative and ethical research to be successful."
Job well done Joe, good luck at AMA!
Ann: Annual Report to shareholders-NEU.AX, page-30
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.02 |
Change
0.080(0.62%) |
Mkt cap ! $1.664B | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.35 | $12.99 | $5.557M | 423.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1588 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.06 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |